Vital Strategies and the National Council for Behavioral Health have developed a toolkit to help jails and prisons implement and expand access to medications for opioid use disorder, such as methadone and buprenorphine, for incarcerated people struggling with opioid dependence.
To reduce vulnerability to opioid overdose and provide quality care for incarcerated individuals with opioid use disorder, the National Council, in partnership with Vital Strategies and faculty from Johns Hopkins University, developed a new resource guide titled: Medication-Assisted Treatment for Opioid Use Disorder in Jails and Prisons: A Planning and Implementation Toolkit with funding support from CDC Foundation and Bloomberg Philanthropies.
People who have been incarcerated are up to 100 times more likely than the general public to die from overdose in the weeks following release from incarceration. Despite high rates of opioid dependence among justice-involved individuals, very few jails and prisons offer access to these medications, which can protect against the risk of death.
Expanding access to methadone and buprenorphine across settings, including jails and prisons, is a top priority for Vital Strategies’ overdose prevention work. We look forward to partnering with state and local governments to ensure these lifesaving medications get to the people who need them.
Report on Legal Framework Assessment on Civil Registration, Vital Statistics and Identification Management…
Integrated Use of Low-Cost Sensors to Strengthen Air Quality Management
Prioritizing Children: Environmental Health Indicators for China
Racial Disparities in United States Overdose Rates
Overdose Prevention Centers
Access to Naloxone to Reduce Overdose Deaths
Access to Safe Use Supplies for Less Harmful Drug Use
Medications for Opioid Use Disorders Prevent Overdose Deaths
Failure or relapse predictors for the STREAM Stage 1 short regimen for RR-TB
Creating Safe Care: Supporting Pregnant and Parenting People Who Use Drugs